Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy
Clinical trial NCT02768714 · WITHDRAWN
Trial details
- NCT number
- NCT02768714
- Sponsor
- Eurofarma Laboratorios S.A.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.